Medik8 is stepping into the PDRN arena.

The U.K.-based clinical skin care brand, which last June was acquired by L’Oréal for $1.1 billion, is introducing a new Exo-PDRN Prismatic+ serum powered by a combination of vegan PDRN and a triple-exosome complex.

Three years in the making, the $96 serum is now available direct-to-consumer and is rolling out to Medik8’s network of more than 7,000 professional clinics and pharmacies across the U.K., Europe, Australia and other geographies.

Related Articles

“There’s a real shift that’s happening in skin care where people are seeking all-around rejuvenation and visible skin health,” said Medik8 cofounder and chief product officer Daniel Isaacs.…